OSAM
ANIK icon

O'Shaughnessy Asset Management’s Anika Therapeutics ANIK Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10
Closed – – 2710
2021
Q2 		$0 Buy
+10
New +$426 ﹤0.01% 2563
2021
Q1 		– Sell
-7
Closed – – 2365
2020
Q4 		$0 Sell
7
-5,884
-100% -$223K ﹤0.01% 2065
2020
Q3 		$209K Sell
5,891
-7,000
-54% -$253K 0.01% 682
2020
Q2 		$487K Sell
12,891
-841
-6% -$27.7K 0.02% 406
2020
Q1 		$399K Sell
13,732
-7,577
-36% -$306K 0.01% 326
2019
Q4 		$1.1M Buy
21,309
+3,110
+17% +$181K 0.02% 257
2019
Q3 		$999K Buy
+18,199
New +$934K 0.02% 265
2018
Q3 		– Sell
-5,177
Closed -$164K – 898
2018
Q2 		$164K Sell
5,177
-7,559
-59% -$311K ﹤0.01% 570
2018
Q1 		$633K Sell
12,736
-41
-0.3% -$2.32K 0.01% 310
2017
Q4 		$689K Buy
12,777
+7,241
+131% +$401K 0.02% 331
2017
Q3 		$321K Buy
5,536
+604
+12% +$31.6K 0.01% 432
2017
Q2 		$243K Sell
4,932
-7,502
-60% -$345K 0.01% 483
2017
Q1 		$540K Sell
12,434
-1,526
-11% -$72.8K 0.01% 347
2016
Q4 		$683K Sell
13,960
-6,183
-31% -$286K 0.02% 314
2016
Q3 		$964K Buy
20,143
+2,203
+12% +$109K 0.02% 275
2016
Q2 		$962K Buy
17,940
+14,332
+397% +$675K 0.02% 275
2016
Q1 		$162K Buy
+3,608
New +$146K ﹤0.01% 485
2015
Q2 		– Sell
-8,285
Closed -$341K – 970
2015
Q1 		$341K Sell
8,285
-11,027
-57% -$446K 0.01% 433
2014
Q4 		$784K Sell
19,312
-20,391
-51% -$797K 0.02% 349
2014
Q3 		$1.45M Sell
39,703
-6,195
-13% -$268K 0.03% 289
2014
Q2 		$2.13M Buy
45,898
+4,196
+10% +$187K 0.04% 252
2014
Q1 		$1.71M Buy
41,702
+17,708
+74% +$658K 0.03% 259
2013
Q4 		$914K Buy
+23,994
New +$740K 0.02% 337

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

O'Shaughnessy Asset Management's ANIK Position: Q3 2021 in Review

O'Shaughnessy Asset Management sold out of Anika Therapeutics (ANIK) in Q3 2021, closing a stake of 10 shares.

O'Shaughnessy Asset Management first reported a position in ANIK in Q4 2013 and held it in 23 quarters. The position peaked at $2.13M in Q2 2014. 131 funds tracked by Wall St. Rank hold ANIK as of Q3 2021.

  • O'Shaughnessy Asset Management reported no remaining Anika Therapeutics position as of Q3 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 10 Anika Therapeutics shares in Q3 2021.
  • O'Shaughnessy Asset Management first reported a position in Anika Therapeutics in Q4 2013 and held it in 23 quarters.
  • O'Shaughnessy Asset Management's Anika Therapeutics position peaked at $2.13M in Q2 2014.
  • 131 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.